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ABSTRACT 
 
Tetraconazole is currently used as a fungicide in fruit and vegetables. The aim of this 
work was the development of immunochemical techniques based on recombinant 
antibodies for the screening of tetraconazole residues in fruit juices. Recombinant 
antibodies were produced from a hybridoma cell line secreting a monoclonal antibody 5 
specific for tetraconazole and from lymphocytes of mice hyperimmunized with 
tetraconazole haptens conjugated to bovine serum albumin. From these antibodies, 
enzyme-linked immunosorbent assays in the conjugate-coated format were developed, 
which were able to detect tetraconazole standards down to 1 ng/mL. From recovery 
studies with spiked samples, these immunoassays determined tetraconazole in orange 10 
and apple juices with acceptable reproducibility (coefficients of variation below 25%) 
and recoveries (ranging from 78−145%) for a screening technique. The analytical 
performance of RAb-based immunoassays was fairly similar to that of the MAb-based 
immunoassays. Due to their simplicity and high sample throughput, the developed 
recombinant-based immunoassays can be valuable analytical tools for the screening of 15 
tetraconazole residues in fruit juices at regulatory levels. 
 
KEYWORDS: immunochemical analysis; recombinant antibodies; scFv; ELISA; 
tetraconazole; fungicide residues; fruit juices 
20 
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1. Introduction 
 
Tetraconazole [(RS)-2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propyl-1,1,2,2-
tetrafluoroethyl ether] is a broad-spectrum systemic fungicide with protective, curative, 
and eradicant properties (Tomlin, 2009). It belongs to the family of triazole fungicides 25 
which exert its antifungal activity by inhibiting the sterol biosynthesis (Stenersen, 
2004). Environmental fate studies indicate that tetraconazole is expected to be persistent 
and moderately to slightly mobile in soil, so it tends to accumulate in soil and has the 
potential to reach surface water via run-off and spray drift. Tetraconazole is moderately 
toxic to freshwater and estuarine/marine fish and freshwater invertebrates, but it is 30 
highly toxic to estuarine/marine invertebrates. At the recommended application rate, 
there are no statistically significant toxic effects to terrestrial or aquatic plants. On an 
oral acute basis, tetraconazole is slightly toxic to mammals and moderately toxic to 
birds. Reproductive chronic effects were observed in birds and mammals. Moreover, the 
United States Environmental Protection Agency classifies tetraconazole as a compound 35 
likely to be carcinogenic in humans (EPA, 2005). 
Tetraconazole is currently an approved active substance in the European Union (EU 
Pesticide Database, 2012). Maximum residue levels (MRLs) were harmonized by the 
European Commission in the Regulation No. 396/2005. According to this regulation, 
tetraconazole levels up to 0.5 mg/kg were fixed in fruit and vegetables. Consequently, 40 
tetraconazole residues can be potentially found in fruit and processed fruit. In fact, 
fungicide residues have been detected at low levels in some orange juices (FDA, 2012). 
Therefore, the availability of a high throughput screening analytical technique for 
tetraconazole residues would be very useful for juice producers and 
regulatory/surveillance agencies. 45 
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The most frequent analytical methods for the determination of azole fungicide 
residues in food are liquid and gas chromatography (Ferrer, Martínez-Bueno, Lozano, & 
Fernández-Alba, 2011). Immunochemical methods can be useful as complementary 
analytical tools to conventional methods for the screening of large number of samples. 
In general, immunoassays are simple to perform, cost-effective, robust, and amenable to 50 
on-site monitoring; however, high quality antibodies are required to develop these 
assays. In past years, ELISAs for the determination of azole fungicides using polyclonal 
antibodies have been reported. Forlani, Arnoldi, and Pagani (1992) obtained polyclonal 
antibodies that recognized tetraconazole and penconazole, with which they developed 
an ELISA that detected tetraconazole between 25-10000 µg/L in fruit (Cairoli, Arnoldi, 55 
& Pagani, 1996). With regard to other azole fungicides, Chen, Dwyre-Gygax, Hadfield, 
Willetts, and Breuil
 
(1996) produced high affinity polyclonal antibodies against 
hexaconazole with a limit of detection (LOD) of 0.1 µg/L in buffer. Danks, Chaudhry, 
Parker, and Baker (2001) developed a polyclonal ELISA to tebuconazole with a 
working range between 0.02-20 mg/L. Szèkács and Hammock (1995) obtained 60 
polyclonal antibodies that detected up to 200 µg/L of myclobutanil. However, the 
development of polyclonal antibodies has several limitations: the quantity of antibodies 
obtained is limited by the animal size and lifespan, and results vary from one animal to 
another. Hybridoma technology provides unlimited quantities of monoclonal antibodies 
(MAbs) and offers the possibility to standardize the assay method. In this sense, we 65 
previously reported the development of sensitive immunoassays based on MAbs for 
conazole fungicides determination in fruit juice. Thus, Manclús, Moreno, Plana, and 
Montoya (2008) described a hexaconazole-specific immunoassay with LOD of 0.3 µg/L
 
and a conazole-specific immunoassay with a LOD between 0.1−0.7µg/L; and Moreno, 
Plana, Montoya, and Manclús (2007) developed an imazalil immunoassay with a LOD 70 
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of 0.6 µg/L. Moreover, Watanabe et al.
 
(2000) obtained MAbs against imazalil and 
applied them to the determination of this fungicide in fruit juices with good recoveries. 
Nevertheless, hybridoma technology is a rather inefficient procedure for selecting high-
sensitivity antibodies because only hundreds of clones are normally assayed from a 10
8
 
lymphocyte population on average. Lately, recombinant antibodies (RAbs) are gaining 75 
importance as immunoanalytical tools of agrochemicals and food contaminants because 
highly diverse antibody libraries and the application of display technologies make the 
antibody selection procedure much more efficient and versatile (Brichta, Hnilova, & 
Viskovic, 2005). In comparison to MAbs, RAbs can be obtained in a more rapid and 
cost-effective process. Moreover, RAb properties can be modified as required (Markus, 80 
Janne, & Urpo, 2011; Fitzgerald, Leonard, Darcy, Danaher, & O’Kennedy, 2011). 
Functional expression of antibody fragments from bacteria was first reported by Bird 
et al. (1988). Over the last years, hapten-specific RAbs have been produced from 
hybridoma cell lines, hyperimmunized animals, and even from non-immunized, generic 
libraries (Brichta, Hnilova, & Viskovic, 2005; Markus, Janne, & Urpo, 2011). 85 
Nevertheless, immunized libraries were a straightforward starting material for obtaining 
high affinity antibodies to low molecular weight compounds (Tout, Yau, Trevors, Lee, 
& Hall, 2001; Kramer & Hock, 2003). 
In this work, the development and application of a recombinant-based screening 
immunoassay of tetraconazole is described. To this aim, we report the successful 90 
cloning and expression in E. coli of RAbs against tetraconazole, starting from the 
genetic material of both hybridoma and spleen cells. Two types of RAb fragments were 
expressed: single-chain variable fragment (scFv) proteins by itself and fused to a 
truncated pIII protein of M13 phage capsid (scFv-pIII fusion proteins) (Mersmann et al., 
1998). Their analytical properties were compared with those of their parental MAb. 95 
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Finally, monoclonal and recombinant-based ELISAs were developed and applied to the 
determination of tetraconazole residues in fruit juices. 
  
2.  Experimental 
 100 
2.1. Materials 
 
Tetraconazole and 2-(2,4-dichlorophenyl)-3-(1H-1,2,4-triazol-1-yl)propanol (DTP, a 
tetraconazole degradation product) analytical standards were from Isagro Ricerca 
(Galliera, Italy). Hexaconazole analytical standard was from Syngenta Agro (Braknell, 105 
UK). Penconazole, cyproconazole, myclobutanil, and triadimefon analytical standards, 
ovalbumin (OVA), o-phenilendiamine (OPD), antibiotics (kanamycin, chloramphenicol 
and tetracycline), 10× Blocking buffer (BB), isopropyl β-D-thiogalacto-pyramoside 
(IPTG), and polyethylene glycol (PEG 8000) were obtained from Sigma-Aldrich 
Quimica (Madrid, Spain). Peroxidase-labeled rabbit anti-mouse immunoglobulins were 110 
obtained from Dako (Glostrup, Denmark). Restriction endonuclease SfiI was purchased 
from Roche Diagnostics (Sant Cugat del Vallés, Spain). T4 DNA ligase was from 
Fermentas (Madrid, Spain). Taq DNA polymerase MasterMix Kit was purchased from 
Eppendorf (Hamburg, Germany) and PCR master mix and Extensor Hi-fidelity PCR 
DNA amplification master mix were from Abgene (Epsom, UK). Electrocompetent E. 115 
coli XL1-Blue (recA1 endA1 gyrA96 thi-1 hsdR17 glnV44 relA1 lac / F' Tn10 (Tet
r
) 
proA
+
B
+
 lacl
q
 Δ(lacZ)M15) cells were from Stratagene (Cedar Creek, TX) and E. coli 
HB2151 (K12, ara Δ(lac-pro) thi / F‘ proA+B+ Δ(lacZ)M15) cells were from Maxim 
Biotech (South San Francisco, CA). M13KO7 helper phage and peroxidase-labeled 
anti-M13 monoclonal antibody were purchased from GE Healthcare (Barcelona, Spain). 120 
 7 
pAK100 phagemid was kindly provided by Dr. A. Plückthun (Institute of Biochemistry, 
University of Zürich, Switzerland). 2×YT medium (1.6% w/v tryptone, 1% w/v yeast 
extract, and 0.5 % w/v NaCl), SOB medium (2% tryptone w/v, 0.5% w/v yeast extract, 
0.05% w/v NaCl, 2.5 mM KCl, and 10 mM MgCl2), and agarose for DNA 
electrophoresis were from Conda Laboratories (Madrid, Spain). Primers were purchased 125 
from Integrated DNA Technologies (IDT) (Coraville, IA). Anti-myc 9E10 hybridoma 
cell line was from American Tissue Type Culture Collection (Rockville, MD). 
Hybridoma fusion and cloning supplement (HFCS) was purchased from Roche 
Diagnostics. Culture media (high-glucose Dulbecco’s Modified Eagle’s medium with 
Glutamax I and sodium pyruvate, DMEM), fetal bovine serum (FBS, myoclone Super 130 
plus), and hypoxantine-thymidine (HT) and hypoxantine-aminopterine-thymidine 
(HAT) supplements were from Gibco (Paisley, Scotland).  
Autoclavable 96-deepwell plates (2.2 mL/well) were obtained from Eppendorf. Flat 
bottom polystyrene ELISA plates (High Binding Plates) were from Costar (Cambridge, 
MA). ELISA plates were washed with a 96 PW microplate washer from SLT 135 
Labinstruments GmbH (Salzburg, Austria), and absorbance was read in dual-
wavelength mode (490-650 nm) with an Emax microplate reader from Molecular 
Devices (Sunnyvale, CA). mRNA concentration was determined by an UV-160A 
Shimadzu spectrophotometer (Kioto, Japan). The electroporator 2510 and the 
Mastercycler gradient thermal cycler were from Eppendorf. The Labofuge 400 140 
centrifuge and the microplate rotor for two 96-well standard plates were from Heraeus 
(Hanau, Germany). The nucleic acid electrophoresis HE 33 unit was purchased from GE 
Healthcare and the Doc-Print gel electrophoresis documentation system was from 
Vilber Lourmat (Marne-la-Vallée, France).  
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Hapten DTPH (Figure 1) and immunoreagents (OVA-DTPH and BSA-DTPH 145 
conjugates, DTPH-41 MAb against tetraconazole) were previously obtained as 
described (Manclús, Moreno, Plana, & Montoya, 2008). 
 
2.2. Immunization procedure 
 150 
Animal manipulation was carried out in accordance with the Spanish regulation 
currently in force and under the approval of the local Ethical Committee for Research. 
BALB/c female mice (8-10 week old) were immunized intraperitoneally with BSA-
DTPH conjugate (100 µg) as an emulsion of a 1:1 (v/v) mixture of PBS (10 mM sodium 
phosphate, 137 mM NaCl , 2.7 mM KCl, pH 7.4) and complete Freund’s adjuvant (250 155 
µL). Two secondary immunizations were performed at three-week intervals using the 
immunogen emulsified in incomplete Freund’s adjuvant. Finally, at least 3 weeks after 
the last injection in adjuvant, an additional boost in PBS was administered 4 days before 
spleen lymphocyte extraction. 
 160 
2.3. Preparation of hybridoma and spleen cells 
 
Hybridoma DTPH-41 cells were thawed in a 37 ºC bath and washed with DMEM. 
After centrifugation at 280g for 5 min, cells were resuspended in 10 mL of DMEM 
containing 1% HT, 1% HFCS, and 10% FBS, and cultured for 3 days. Hybridoma cells 165 
were centrifuged, counted and used for mRNA extraction. 
On the other hand, spleen was excised and splenocytes released from the sac in 
DMEM medium. After filtration and centrifugation at 328g for 5 min, spleen cells were 
resuspended in 50 mL of the same medium, counted, and used for mRNA extraction. 
 9 
 170 
2.4. Cloning of scFv fragments and library construction 
 
2.4.1. mRNA isolation and cDNA synthesis  
mRNA was purified from hybridomas (5×10
7
 cells) and lymphocytes (1×10
7
 cells) 
using the QuickPrep Micro mRNA purification kit (GE Healthcare) and RNeasy kit 175 
(Qiagen), respectively. Extracted mRNA was precipitated with ethanol, resuspended in 
molecular biology grade water and quantified by spectrophotometry. About 100 ng of 
mRNA was reverse-transcripted using random hexamer polymers and the first strand 
cDNA synthesis kit from GE Healthcare. 
 180 
2.4.2. Synthesis of VH and VL genes from cDNA 
 cDNA was then used for the amplification of the variable region of heavy- (VH) and 
light-chain (VLκ) domains using a primer set described by Krebber et al. (1997) with 
slight modifications. Taq polymerase and Hi-Fidelity polymerase were used for 
hybridoma and lymphocyte variable chain amplification, respectively. PCR reactions 185 
were performed under the following conditions: 5 cycles of 1 min at 92 ºC, 1 min at 50 
ºC, and 1 min at 72 ºC; and 20 cycles of 1 min at 92 ºC, 1min at 62 ºC, and 1 min at 72 
ºC. PCR products were concentrated by using MicroconYM30 centrifugal filter devices 
(Millipore, Bedford, MA). VL and VH genes were purified by preparative agarose gel 
electrophoresis, using the MiniElute Gel Extraction Kit from Qiagen (Izasa, Barcelona, 190 
Spain), and quantified by analytical gel electrophoresis using DNA molecular weight 
markers from Fermentas. 
 
2.4.3. Construction of scFv fragments 
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Equimolecular amounts of both chains were assembled by splicing using overlap 195 
extension PCR (SOE-PCR). For scFv synthesis from hybridomas, the experimental 
procedure described by Krebber et al. (1997) was followed. For scFv synthesis from 
lymphocytes, some modifications were introduced. An initial denaturation at 92 ºC for 3 
min was followed by the addition of the Hi-fidelity polymerase and 7 cycles of 1 min at 
92 ºC, 30 s at 63 ºC, 50 s at 58 ºC, and 1 min at 72 ºC in the absence of primers. After 200 
adding the outer primers scback and scfor (Krebber et al., 1997), 23 cycles of 1 min at 
92 ºC, 30 s at 63 ºC, and 1 min at 72 ºC were performed, followed by 5 min at 72 ºC. 
scFv fragments were purified by gel electrophoresis as above. 
  
2.4.4. Cloning into pAK100 and transformation 205 
 ScFv fragments were digested with SfiI for 3 h at 50 ºC. After purification, 20 ng of 
the fragment were ligated into the SfiI-digested pAK100 vector (molar ratio 
vector:insert, 3:2). The ligated product was purified and concentrated by ethanol 
precipitation. For each transformation, 1 µL at 5 ng/µL (referred to ng of insert) was 
used to transform 40 µL of electrocompetent E.coli XL1-blue cells prepared as 210 
described in the following section (scFv from hybridomas) or 40 µL of 
electrocompetent E.coli XL1-blue cells from Stratagene (scFv from lymphocytes). 
Electroporated cells were plated into 2×YT-agar plates containing 1% glucose and 25 
µg/mL chloramphenicol (2×YT+G+C medium) and incubated overnight at 37 ºC. 
Several colonies were selected for screening and the rest were scrapped off the plate 215 
into 2 mL of 2×YT and stored at -70 ºC after addition of 15% glycerol. 
 
2.4.5. Production of electrocompetent E. coli cells 
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 Ten mL of an E.coli overnight culture was inoculated into 200 mL of fresh SOB 
medium and incubated at 37 ºC until an optical density at 550 nm (OD550) of 0.6 was 220 
reached. The culture was chilled on ice for 10 min and centrifuged (3700g) for 15 min 
at 4 ºC. The pellet was suspended in the same volume of MilliQ sterile water. This step 
was repeated once again. Then, the pellet was suspended in 40 mL of milliQ sterile 
water with 10% of glycerol and centrifuged for 10 min. The volume of pellet was 
determined and it was resuspended in the same volume of water with 10% glycerol, 225 
frozen in liquid nitrogen and stored at -70 ºC in 100 µL aliquots. 
 
2.5. Screening by phage ELISA 
 
2.5.1. Phage recovery 230 
 Single colonies were picked into 96-well culture plate containing 150 µL of 
2×YT+G+C medium per well and incubated at 37 ºC with orbital shaking at 250 rpm 
until an OD550 of 0.5 was reached. After adding 50 µL of 2×YT+G+C medium 
complemented with 2 mM IPTG and 2.5×10
8
 cfu of helper phage M13K07, plates were 
incubated overnight at 30 ºC with shaking. Then, plates were centrifuged at 1500g for 5 235 
min and supernatants were recovered. 
 
2.5.2. Phage ELISA 
ELISA plates were coated overnight with OVA-DTPH and OVA (1 µg/mL) in coating 
buffer (50 mM carbonate buffer, pH 9.6). Each well was blocked with 100 µL of 1× 240 
blocking buffer (BB) for 1 h at room temperature. After emptying plates, 100 µL of 
supernatant samples were added and incubated for 1 h. Samples were prepared by 
diluting supernatants with the same volume of 2× BB and incubating for 30 min. After 
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washing 5 times with 1× BB, plates were incubated for 1h with 100 µL of peroxidase-
labeled anti-M13 monoclonal antibody (1/5000 in 1× BB). Finally, plates were washed 245 
and revealed as described in section 2.10.  
  
2.6. Screening by soluble scFv ELISA 
 
Colonies were picked into a 96-deepwell (2.2 mL) culture plate containing 400 µL 250 
2×YT+G+C medium. After incubating overnight at 30 ºC with orbital shaking at 250 
rpm, 40 µL were inoculated into 400 µL of fresh medium and incubated at the same 
temperature until an OD550 of 0.4 was reached. After centrifugation at 1000g for 5 min, 
the pellet was resuspended in 400 µL of 2×YT medium containing 1 mM IPTG and 25 
µg/mL chloramphenicol, and incubated overnight at 30 ºC with shaking. Then, 100 µL 255 
of 0.5% Tween 20 in water was added to each well and the plate was incubated for 3 h 
at 30 ºC with shaking at 200 rpm. After centrifuging at 1000g for 10 min, the 
supernatant was checked by ELISA. 
General ELISA conditions are described in section 2.10. Plates were coated overnight 
with OVA-DTPH (1µg/mL) in coating buffer. Then, diluted supernatants (1/2 in PBS) 260 
were added to each well and incubated for 1 h. After washing, anti-myc MAb at 1 
µg/mL in PBS-T (PBS containing 0.05% Tween 20) was added and incubated for 1 h. 
Next, plates were incubated for 1 h with peroxidase-labeled rabbit anti-mouse 
immunoglobulins (1/2000 in PBS-T). Finally, peroxidase activity was revealed as 
described in section 2.10. Inhibition assays to ascertain binding to free analyte were 265 
performed as above with the addition of the fungicide in the supernatant reaction step. 
 
2.7. Panning 
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2.7.1. Production of recombinant phages 270 
To rescue scFv displaying phages, 5 mL of 2×YT+G+C medium were inoculated with 
10
8
 cells from the glycerol library stock and incubated at 37 ºC with shaking until a 
OD550 of 0.5 was reached. Next, 10
10
 cfu of helper phage and 2.5 µL of 1 M IPTG were 
added. After incubating for 15 min at 37 ºC without shaking, 5 mL of 2×YT+G+C 
medium containing 0.5 mM IPTG was added. The culture was incubated for 2 h at 26 275 
ºC and kanamycin at 30 µg/mL was then added, followed by an overnight incubation. 
Two aliquots of 1.1 mL from the overnight culture were centrifuged at 1000g for 15 
min at 4 ºC. To 1 mL of supernatant of each tube, 250 µL of PEG/NaCl (20% w/v 
Polyethilenglycol 8000 in 2.5 M NaCl) was added, gently mixed by inversion, and kept 
on ice for 30 min. After centrifugation at 10000g for 15 min at 4 ºC, supernatants were 280 
removed and pellets were resuspended in 1 mL of 2×YT medium. Finally, phages were 
sequentially filtered with 3 and 0.45 µm filters, titered by infecting E. coli XL1-Blue 
and plating into 2×YT agar plates. For long time storage, glycerol up to 30% was added 
and phages were frozen at -70 ºC. 
 285 
2.7.2. Selection of tetraconazole binding recombinant phages 
ELISA plate wells were coated overnight at room temperature with 10 µg/mL OVA-
DTPH (100 µL) in sterile coating buffer. Control panning with OVA coated wells at the 
same concentration was carried out in parallel. Wells were washed 3 times with 300 µL 
of 1× BB and blocked for 1 h with 200 µL of the same buffer. In parallel, a solution of 290 
10
10
 phages per mL of BB was incubated for 30 min at 37 ºC. After emptying the well, 
10
9
 phages in 100 µL of BB were added and incubated for 1 h at room temperature. 
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Unbound phages were removed by washing 5 times with 300 µL of 1× BB, aspirating 
and dispensing with a pipette 5 times for every wash.  
To elute bound phages, 100 µL of 100 nM analyte in 1× BB was added to each well 295 
and incubated for 30 min at room temperature with shaking at 100 rpm. Eluted phages 
were used to infect 100 µL of E. coli XL-1blue cells (DO550 between 0.4 and 0.8). After 
30 min of incubation at 37 ºC, infected cells were plated into 2×YT+G+C agar plates 
and incubated overnight at 37 ºC. Some colonies were checked by screening ELISA and 
the rest were scrapped off the plates and stored at -70 ºC with 15% glycerol for 300 
subsequent rounds of panning. 
 
2.8. Soluble Expression of scFv Fragments 
 
The expression of scFv gene fragments was carried out following the protocol 305 
described by Kipriyanov, Moldenhauer, and Little (1997) with minor modifications. 
 
2.8.1. Expression of scFv-pIII fusion proteins 
Single colonies were inoculated into 10 mL of 2×YT+G+C medium and incubated 
overnight at 37 ºC with shaking at 250 rpm. Two mL of overnight cultures was 310 
inoculated into 100 mL of fresh medium and incubated until an OD550 of 0.8 was 
achieved. Cultures were centrifuged at 1500g for 10 min and pellets were resuspended 
in 100 mL of 2×YT containing 0.4 M saccharose, 25 µg/mL chloramphenicol, and 0.1 
mM IPTG, and incubated overnight between 24-30ºC. Overnight cultures were 
centrifuged at 5000g for 10 min at 4 ºC. Supernatants were cleaned by centrifugation at 315 
30000g for 20 min at 4 ºC. Pellets were resuspended in 5 mL of periplasmic extraction 
buffer (50 mM tris/HCl, 20% sucrose, and 1 mM EDTA) and incubated for 1 h in ice 
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with occasional shaking. After centrifugation at 30000g for 30 min at 4 ºC, periplasmic 
supernatants were recovered. Both, culture medium and periplasmic supernatants were 
analyzed as previously described in section 2.6. Next, supernatants were concentrated 320 
using ultra-filtration cells from Amicon (Beverly, CA) and stored at -20ºC. 
  
2.8.2. Expression of soluble scFv 
For the expression of soluble scFv antibody fragments, the corresponding pAK100-
scFv phagemid was purified using the commercial kit Perfectprep
®
 plasmid mini 325 
(Eppendorf). After quantification by electrophoresis, 200 µL of competent, non-
suppressor E. coli HB2151 cells was transformed with 10 µL of 5 ng/µL pAK100-scFv 
by the CaCl2 procedure and plated into 2×YT+G+C containing 25 µg/mL nalidixic acid. 
Transformed colonies were checked by screening ELISA and positive colonies were 
used to obtain scFv proteins using the same protocol as for scFv-pIII fusion proteins. 330 
 
2.9. Sequence determination 
 
The ABI PRISM Big Dye Terminator Cycle Sequencing Kit v3.1 (Applied 
Biosystems) was used for cycle sequencing with fluorescently labelled 335 
dideoxynucleotides. Cycle sequencing reactions were carried out on an ABI GeneAmp 
PCR System 9700 thermal cycler. Sequencing products were analysed by capillary 
electrophoresis on an ABI 3100 Genetic Analyser (Applied Biosystems). The primers 
used were 5’-CAG GAA ACA GCT ATG ACC-3´ and 5’-CTT ATT AGC GTT TGC 
CAT-3’. The DNA sequence was translated into aminoacid sequences using the 340 
Chromas 2.01 software (www.technelysium.com.au). 
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2.10. Tetraconazole ELISA based on monoclonal antibody 
 
ELISA was performed by adding a volume of 100 µL per well throughout all assay 345 
steps. All the incubations were carried out at room temperature and, after each 
incubation, plates were washed four times with washing solution (0.15 M NaCl 
containing 0.05% Tween 20). Plates were coated overnight with 1 µg/mL of OVA-HH 
(Manclús, Moreno, Plana, & Montoya, 2008). After washing, 50 µL of MAb DTPH 4.1 
(0.06 µg/mL in PBS 0.0025%) followed by 50 µL of standards or samples were added. 350 
Next, plates were incubated for 1 h with peroxidase-labeled rabbit anti-mouse 
immunoglobulins (1/2000 in PBS-T). Finally, peroxidase activity was revealed with 2 
mg/mL OPD and 0.012% H2O2 in 25 mM citrate and 62 mM sodium phosphate buffer, 
pH 5.35. The reaction was stopped 10 minutes later by adding 2.5 M H2SO4 and the 
absorbance was read at 490 nm using 650 nm as the reference wavelength. 355 
  
2.11. Tetraconazole ELISA based on recombinant antibodies 
 
For recombinant antibody ELISAs, plates were coated with OVA-DTPH at 0.25 
µg/mL for hybridoma-derived RAb ELISA or at 0.5 µg/mL for lymphocyte-derived 360 
RAb ELISA. At the competition step, 50 µL of supernatant diluted in PBS with 
0.0025% Tween 20 was added together with 50 µL of standards or samples. The rest of 
the assay was performed as described in section 2.6. 
 
2.12. Preparation of tetraconazole standards and spiked juices 365 
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Tetraconazole serial dilutions were prepared in DMF from a 1 mM stock stored at -20 
ºC. For recombinant assays, eight serial 3-fold dilutions were made from a 372.1 µg/mL 
concentration. Standards were prepared daily by diluting 1/500 in PBS. As the assay 
involved the addition of the same volume of the antibody dilution, final standard 370 
concentrations were 372.10, 124.03, 41.34, 13.78, 4.59, 1.53, 0.51, and 0.17 ng/mL. For 
monoclonal assays, eight serial 5-fold dilutions were made from a 100 µg/mL 
concentration. Final standard concentrations in assay were 100, 20, 4, 0.8, 0.16, 0.03, 
0.0064, and 0.00128 ng/mL. 
Apple and orange juices were obtained from a local supermarket. We assumed that 375 
these juices did not contain tetraconazole residues. The juices were spiked with 
tetraconazole at 1, 2, and 5 µg/mL by adding adequate analyte concentrations in PBS 
prepared from stock solutions in DMF. For ELISA determinations, spiked juice samples 
were directly analyzed just diluting 1/500, 1/1000, and 1/2500 in PBS, respectively, for 
the MAb-based ELISA, and 1/100, 1/100, and 1/500, respectively, for RAb-based 380 
ELISAs. After dilution, all fortification levels entered into their respective assay 
working ranges. Samples were analyzed four times independently. 
 
2.13. Data analysis 
 385 
Standards and samples were run in triplicate wells and mean absorbance values were 
processed. Standard curves were obtained by plotting absorbance values against the 
logarithm of analyte concentration. Sigmoid curves were fitted to a four-parameter 
logistic equation, using commercial software (Sigmaplot, Jandel Scientific) as 
previously reported (Moreno, Plana, Montoya, & Manclús, 2007). Tetraconazole 390 
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concentrations in fruit juices were obtained by interpolating mean absorbance values in 
the standard curve run in the same plate (SOFTmax Pro Software, Molecular Devices). 
 
3. Results and discussion 
 395 
3.1. Production of tetraconazole scFv RAbs from hybridomas 
 
The hybridoma cell line secreting DTPH-41 MAb specific to tetraconazole was 
previously obtained and characterized by Manclús, Moreno, Plana, and Montoya 
(2008). The selected MAb was an IgG1 kappa isotype. mRNA was isolated from 400 
hybridoma cells and used for first strand cDNA synthesis. Heavy and kappa light 
variable domains (VH and VLκ) were amplified and the predominant PCR products were 
of the expected sizes (data not shown). These VH and VLκ genes were purified and 
assembled into a 750 bp scFv gene using an overlap extension of the nucleotide 
sequence of the flexible linker (Gly4-Ser)3. (Krebber et al., 1997).
 
405 
The purified scFv DNA was cloned into the phagemid vector pAK100. This vector 
allows the RAb expression as functional scFv-pIII fusion proteins, both as soluble 
proteins and as recombinant phages presenting the fusion protein on the phage surface. 
Transformation of E. coli XL1-blue cells with the recombinant phagemid yielded a 
library of 5×10
4
 transformed colonies. To detect positive clones, two screening methods 410 
were assayed: phage ELISA and soluble scFv-pIII ELISA. 
Forty eight colonies were randomly picked and screened by phage ELISA and soluble 
scFv ELISA, performing non-competitive and competitive (100 nM tetraconazole as 
competitor) assays simultaneously. In both cases, about 75% of the colonies were 
screened as positive (A490 >1 in non-competitive assays), and 90% of the positive 415 
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colonies were screened as competitive (evident signal reduction in the presence of 100 
nM tetraconazole). Usually, complete signal inhibition was achieved in the soluble scFv 
ELISA while just a signal decrease was observed in the phage ELISA. This fact pointed 
out that recombinant scFv-displaying phages, because of their size and complexity, 
were prone to unspecific interactions, which may mask analyte recognition in 420 
competitive assays. Moreover, Tout, Yau, Trevors, Lee, and Hall
 
(2001) reported that 
scFv phages competed much more weakly than soluble scFv for binding to the herbicide 
picloram, which could be attributed to differences in the valency and folding of antigen 
binding sites of phage-bound (pentavalent) versus soluble scFv antibody fragments. 
Therefore, we decided to carry out the screening of small ligand-binding RAb libraries 425 
by the soluble scFv ELISA. 
Three of the competitive colonies showing a high signal in absence of analyte were 
selected. Their culture supernatants were assayed against several concentrations of 
tetraconazole and all the colonies showed the same profile. One of them was selected 
and named as RAb DTPH H-4.1. 430 
 
3.2. Production of tetraconazole scFv RAbs from lymphocytes 
 
As other authors reported (Tout, Yau, Trevors, Lee & Hall,
 
2001), VL amplification 
and scFv assembly from the genetic material of lymphocytes were problematic. The 750 435 
bp scFv migrating fragment appeared as a wide, undefined smear with fragments of 
unexpected size in the electrophoresis gel. To solve this problem two additional 
polymerases from Abgene (PCR Master Mix and Extensor Hi-Fidelity PCR master mix) 
and different PCR conditions were checked. The highest yield of scFv fragment was 
achieved using Hi-Fidelity polymerase and the PCR conditions described in Material 440 
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and Methods. In addition, as most MAbs to small molecules reported on the literature 
were IgG1κ isotype (Dübel et al., 1994), only VLκ domains were amplified and used to 
obtain the scFv fragment. This fragment was purified, digested, and cloned into 
pAK100 in the same way as the fragment coming from hybridomas. Finally, four 
independent transformations gave 3×10
4 
transformed colonies. This library size was 445 
considered as adequate taking into account that it came from immunized lymphocytes. 
Likewise, Tout, Yau, Trevors, Lee, and Hall.
 
(2001) reported the isolation of high-
affinity scFv against small molecules from an immunized library of similar size (10
4
). 
As expected, the initial screening of 96 clones did not render positive colonies. To 
enrich the library with positive colonies, a round of panning was undertaken. At this 450 
point, we took into account the fact that some researchers have proved the usefulness of 
competitive elution with analytes in the enrichment of clones producing scFv antibodies 
with high-affinity and specificity for small-ligand targets (Brichta, Hnilova & Viskovic, 
2005). Then, plates were coated with 10 µg/mL of OVA-DTPH and bound recombinant 
phages were competitively eluted with 100 nM tetraconazole. Recovered phages from 455 
the first round of affinity selection were used to infect E. coli XL1-Blue cells. After 
plating on agar, 41 colonies were obtained and all of them were analyzed by 
competitive and non competitive soluble fragment ELISA. Seven colonies were positive 
and three of them showed clear signal reduction in presence of 100 nM tetraconazole. 
These three RAbs were studied in depth and only two unique sequences were identified, 460 
RAb DTPH L-1.1 and RAb DTPH L-1.2. 
Since all the colonies obtained after the first round of panning were checked, it made 
no sense applying additional rounds of affinity selection. Additional rounds would just 
increase the proportion of the same positive clones in our population. Therefore, the 
specific elution procedure followed in this study allowed us to obtain high-affinity RAb 465 
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against small ligands in the first round of panning. In contrast, the application of 
unspecific elution required several rounds of panning to isolated RAb recognizing 
analytes with high affinity, as reported by other authors (Tout, Yau, Trevors, Lee, & 
Hall,
 
2001; Li et al., 2006). 
 470 
3.3. Sequence analysis 
 
DNA fragments of the three selected scFv to tetraconazole, one derived from a 
hybridoma (RAb DTPH H-4.1) and two derived from lymphocytes (RAb DTPH L-1.1 
and RAb DTPH L-1.2), were sequenced and their respective amino acid sequences were 475 
deduced. Segment designation and amino acid numbering were assigned according to 
Kabat, Wu, Perry, Gottesman, and Foeller
 
(1991). Amino acid sequence alignment is 
shown in Table 1. As it can be seen, the identities of the variable domains are higher 
than 90%, except for VH of RbAb DTPH L-1.2 (identity of 85%). Approximately half of 
the amino acid substitutions are located in complementary determining regions (CDRs). 480 
It is noteworthy that the affinity to tetraconazole of the three scFv was very similar, 
being their amino acid sequence significantly different. This is especially evident for VH 
CDR of RAb DTPH L-1.2.  
On the basis of comparative studies of known antibody structures and sequences, it 
has been argued that there is a small repertoire of main-chain conformations for at least 485 
five out of the six hypervariable regions of antibodies, and that the particular 
conformation adopted is determined by a few key conserved residues. The commonly 
occurring main-chain conformations of the hypervariable regions are called canonical 
structures (Clothia & Lesk, 1987). Amino acid sequences of the three RAbs were 
analyzed using AbCheck and applying auto-generated SDR (specificity-determining 490 
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residues) templates (Martin, 1996). RAb DTPH H-4.1 and RAb DTPH L-1.2 showed 
similar results; CDRs L2 and L3 were identified as canonical class 1/7A and 1/9A, 
respectively; whereas CDR L1, H1, and H2 were similar, but no identical, to class 
4/16A, 1/10A, and 2/10A, respectively. Canonical class assignment for RAb DTPH 
L1.1 showed almost the same results, except for CDR H1 that matched exactly 1/10A 495 
class. 
  
3.4. ScFv expression and characterization 
 
Soluble scFv antibodies were obtained following the protocol described by 500 
Kipriyanov, Moldenhauer, and Little (1997). Two E. coli strains were used for 
expression: E. coli XL1-Blue suppressor strain was used for expressing scFv-pIII fusion 
proteins, and E. coli HB2151 non suppressor strain was used for expressing soluble 
scFv proteins. Both types of fragments were produced to study the influence of an 
additional protein fragment (pIII) on RAb analytical characteristics. The expression of 505 
antibody fragments fused to a protein like pIII may increase protein solubility and hence 
soluble expression yield; moreover, the pIII protein can be used as a tag for rapid 
detection and purification of scFv (Mersmann et al., 1998). In addition, the production 
of fusion proteins involves fewer steps than soluble scFv.  
Preliminary characterization of the two RAbs derived from lymphocytes showed that 510 
both had a very similar affinity to tetraconazole. During the characterization process, 
RAb DTPH L-1.1 proved to be unstable, as evidenced by a signal decrease over the 
time (data not shown). Instability of the VH−VL interaction that favours aggregation has 
been hypothesized to be the main cause of scFv inactivation (Leong & Chen, 2008). 
Therefore, this RAb was discarded for the application study. Competitive ELISAs in the 515 
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conjugate-coated format were designed and optimized from each antibody type. 
Standard curves of optimized tetraconazole ELISAs configured with MAb DTPH 4.1, 
RAb DTPH H-4.1, and RAb DTPH L1.2 are shown in Figure 2. Only scFv curves have 
been represented because scFv-pIII curves were almost identical. Analytical parameters 
of their respective competitive inhibition curve are shown in Table 2. For DTPH 4.1 520 
MAb, the concentration giving 50% inhibition of the maximum absorbance (I50 value) 
was 0.5 ng/mL tetraconazole, while I50 values for RAbs were between 5.7 and 8.6 
ng/mL. Other parameters, such as LOD and working range, maintained a similar ratio 
between monoclonal and recombinant antibodies. Comparing RAb data, both of them, 
hybridoma or lymphocyte derived, showed similar parameters. Moreover, analytical 525 
parameters were also fairly the same regardless of the RAb type, soluble scFv or fusion 
scFv-pIII. In general, all RAbs obtained in this study displayed one order of magnitude 
lower affinity (higher I50 value) to the analyte than MAb DTPH 4.1. When the RAb 
affinity and that of its parental MAb have been compared in the literature, diverse 
results have been reported. While some authors reported that RAbs showed lower 530 
affinity than its parental MAb  (Kramer & Hock, 1996; Graham, Porter, & Harris, 1995; 
Choi et al., 2004), i.e. the same behaviour as we found, others reported a comparable 
(Tout, Yau, Trevors, Lee, & Hall, 2001; Alcocer, Doyen, Lee, & Morgan, 2000; Nishi, 
Ishiuchi, Morimune, & Ohkawa, 2005) or even higher (Alcocer, Doyen, Lee, & 
Morgan, 2000; Strachan, Grant, Learmonth, Longstaff, Porter, & Harris, 1998; Pan et 535 
al., 2006) affinity of RAbs over their counterpart MAbs. Results obtained in this study 
and those reported in the literature suggest that the folding of each scFv and, therefore, 
their analyte interaction properties depend on its particular amino acid sequence. 
 
3.5. Cross Reactivity 540 
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The specificity of each antibody was evaluated by performing competitive ELISAs in 
the conjugate–coated format with structurally related compounds as competitors and 
comparing their respective I50 values. Cross-reactivity data for the MAb and RbAbs are 
presented in Table 3. In general, all the antibodies assayed showed a similar cross 545 
reactivity profile characterized by a high recognition of penconazole and DTP 
(tetraconazole degradation product) and a low recognition of hexaconazole and 
triadimefon. Furthermore, all of them recognized myclobutanil and cyproconazole to 
different extents. In particular, RAb DTPH H-4.1 cross-reactivity for almost all the 
compounds was slightly higher than that of the MAb, whereas RAb DTPH L-1.2 cross-550 
reactivity for cyproconazole and triadimefon was lower than that of the other antibodies. 
Concerning to both types of recombinant fragments, cross-reactivity patterns of soluble 
scFv and fusion protein scFv-pIII were nearly identical. 
 
3.6. Analysis of spiked juice samples 555 
 
It has been previously proved that the MAb-based immunoassays can precisely and 
accurately determine triazole fungicide residues in fruit juices (Manclús, Moreno, Plana, 
& Montoya, 2008). To test the analytical performance of RAb-based immunoassays, 
optimized conjugate-coated ELISAs were applied to the determination of tetraconazole 560 
in spiked fruit juices. Apple and orange juices were spiked with tetraconazole at 1, 2, 
and 5 µg/mL, and directly analyzed by these immunoassays without any treatment other 
than dilution in PBS (at least 1/100) to minimize matrix effects. Taking into account this 
dilution and the limit of detection range in buffer, the actual LODs of RAb-based 
immunoassays for tetraconazole in apple and orange juices were in the 0.1−0.2 µg/mL 565 
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range. Table 4 summarizes the results obtained for each spiked juice. In general, 
coefficients of variations can be considered as acceptable, most of them were below 
20%. For apple juice, recoveries were fairly good, ranging from 78 to 119 %, regardless 
of the antibody type used. For orange juice, acceptable recoveries were obtained with 
the MAb-based assay, while the RAb-based assays tended to overestimate as recoveries 570 
ranged from 100 to 145 %. Finally, both scFv and scFv-pIII fragments showed almost 
identical behavior in tetraconazole determination in fruit juices. On the other hand, non-
spiked juice samples were also included in the analysis as negative controls. 
Tetraconazole concentrations below the detection limit of the assays were found in all 
negative samples. 575 
  
4. Conclusion 
 
RAbs for tetraconazole were produced from a hybridoma cell line and from 
lymphocytes of hyperimmunized mice. They are the first reported for this fungicide. 580 
With these RAbs, immunoassays with LOD about 1−2 ng/mL for tetraconazole 
standards were developed. The sensitivity of these immunoassays is higher than that of 
the polyclonal antibody-based immunoassay developed by Forlani et al. (1992) but 
lower than that of the monoclonal antibody-based immunoassay developed by our group 
(Manclús, Moreno, Plana, & Montoya, 2008). Nevertheless, RAbs can be obtained in a 585 
more rapid, cost-effective manner than monoclonal antibodies. 
For tetraconazole determination in apple and orange juices, only a 1/100 dilution in 
buffer is required to minimize matrix effects. Under these conditions, the practicability 
of this screening technique has been demonstrated since the fungicide residues content 
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in the fruit juices tested can be measured down to 100 ng/mL with acceptable accuracy 590 
and precision for a screening technique.  
To the best of our knowledge, this work is the first report on the application of RAbs 
to pesticide residue analysis in food. The major advantage of this immunochemical 
technique over existing methods is its high sample throughput because as many as 120 
juice samples can be determined daily by an analyst. 595 
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Figure captions: 
 
Figure 1. Structure of tetraconazole and of the immunizing hapten DTPH.  
 
Figure 2. ELISA standard curves for tetraconazole using MAb DTPH 4.1 (■), RAb 
DTPH H-4.1 (●) and RAb DTPH L-1.2 (▲). Each point represents the mean value of 
four replicates ± standard deviation. 
 
  
 
 
 
RAb Light chain (VL) 
  
 FR-1 
DTPH H-4.1 D V V M T Q T P L S L P V S L G D Q A S I S C          
DTPH L-1.2 – I – – – – S – – – – – – – – – – – – – – – –          
DTPH L-1.1 – I – – – – S – – – – – – – – – – – V – – – –          
 CDR-L1                 
DTPH H-4.1 R S S Q S V V H S N G N T Y L Q                 
DTPH L-1.2 – – – – – I – – – – – – – – – E                 
DTPH L-1.1 – – – – N I – – – T T – – – – –                 
 FR-2                  
DTPH H-4.1 W F L Q K P G Q S P K L L I Y                  
DTPH L-1.2 – Y – – – – – – – – – – – – –                  
DTPH L-1.1 – I – – – – S – – – – – – – –                  
 CDR-L2                          
DTPH H-4.1 K V S N R F S                          
DTPH L-1.2 – – – – – – –                          
DTPH L-1.1 – – – – – – –                          
 FR-3 
DTPH H-4.1 G V P D R F S G S G S G T D F T L K I S R V E A E D L G V Y Y C 
DTPH L-1.2 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 
DTPH L-1.1 – – – – – – – S – – – – – – – – – – – – – – – – – – – – – – – – 
 CDR-L3                        
DTPH H-4.1 F Q G S H V P W T                        
DTPH L-1.2 – – – – – – – – –                        
DTPH L-1.1 – – – – – – – – –                        
 FR-4                      
DTPH H-4.1 F G G G T K L E L K R                      
DTPH L-1.2 – – – – – – – – I – –                      
DTPH L-1.1 – – – – – – – – – – –                      
 
a
 Identical aminoacids to RAb DTPH H-4.1 are indicated with a dash (−).
Table 1 
Comparison of deduced aminoacid sequences of RAbs derived 
from hybridoma and lymphocyte cells.
a
  
RAb Heavy chain (VH) 
  
 FR-1 
DTPH H-4.1 Q V Q L Q Q S G A E L A K P G A S V K M S C K A S D Y T F T   
DTPH L-1.2 – – – – – – – – – – V T – – – – – – – – – – – – – G – – – I   
DTPH L-1.1 – – – – – – – – – – – – – – – – – – – – – – – – – G – – – –   
 CDR-H1                 
DTPH H-4.1 R Y W M H                            
DTPH L-1.2 S S – – –                            
DTPH L-1.1 S – – – –                            
 FR-2                  
DTPH H-4.1 W V K Q R P G Q G L E W I G                   
DTPH L-1.2 – – – E – – – – – – – – – –                   
DTPH L-1.1 – – – – – – – – – – – – – –                   
 CDR-H2                
DTPH H-4.1 Y I N P S T G Y T E Y N Q K F K D                
DTPH L-1.2 W – Y – R – – H I – – – – – – – –                
DTPH L-1.1 – – – – – – – – – – – – – – – – –                
 FR-3 
DTPH H-4.1 K A T L T A D I S S S T A Y M Q L S S L T S E D S A V Y Y C A R 
DTPH L-1.2 – – – – – – – S – – T – – – – – – – – – – – D – – – – – – – – – 
DTPH L-1.1 – – – – – – – K – R K – – – – – – – – – – – – – – – – – – – – N 
 CDR-H3                        
DTPH H-4.1 A T N Y A M D Y                         
DTPH L-1.2 – G Y D – L – –                         
DTPH L-1.1 – D Y D – – – –                         
 FR4                      
DTPH 4.1 W G Q G T S V T V S S A                     
DTPH 1.2 – – – – – – – – – – – –                     
DTPH 1.1 – – – – – – – – – – – –                     
Table(s)
  
 
Table 2 
Analytical Characteristics of Tetraconazole Immunoassays Based on 
MAb and RAbs. 
Antibody 
I50 
(ng/mL) 
Working 
range 
(ng/mL) 
LOD 
(ng/mL) 
MAb DTPH 4.1 0.5 0.2-1.6 0.1 
RAb DTPH H-4.1 8.5 3.8-18.5 2.2 
RAb-pIII DTPH H-4.1 8.6 3.4-20.3 1.8 
RAb DTPH L1.2 6.4 2.5-15.0 1.3 
RAb-pIII DTPH L-1.2 5.7 1.9-15.4 0.9 
 
  
Table 3 
Cross-reactivity
a
 of Tetraconazole Antibodies towards Several Triazole Compounds  
                   Recombinant antibodies 
Chemical structure Compound 
MAb 
 DTPH 4.1 
scFv 
DTPH H-4.1 
scFv-pIII 
DTPH H-4.1 
scFv 
DTPH L-1.2 
scFv-pIII 
DTPH L-1.2 
N
N
N CH2 CH
Cl
Cl
CH2OCF2CHF2
 
Tetraconazole 100 100 100 100 100 
N
N
N CH2 CH
Cl
Cl
CH2CH2CH3
 
Penconazole 44 87 90 64 47 
N
N
N CH2 C
Cl
OH
CH2CH2CH2CH3
Cl
 
Hexaconazole <0.1 0.5 0.7 <0.1 <0.1 
N
N
N CH2 CH
Cl
CH2 OH
Cl
 
DTP 24 58 50 40 29 
N
N
N CH2 C CHCH3
Cl
OH
 
Cyproconazole 32 63 50 7 5 
N
N
N CH2 C CH2CH2CH2CH3
Cl
C
N
 
Myclobutanil 14 33 26 13 11 
N
N
N CH O Cl
C O
C(CH3)3
 
Triadimefon 1 1 1 0.2 0.1 
 
 * Cross reactivity was calculated as (I50 tetraconazole /I50 compound) x 100. 
 
 
  
Table 4 
Reproducibility and Accuracy of Tetraconazole Immunoassays in Spiked Fruit Juice 
Samples 
 
 
Immunoassay develop 
with 
 Apple juice Orange juice 
Spiked 
level  
(ng/mL) 
Founda 
(ng/mL) 
CV      
(%) 
Recovery 
(%) 
Founda 
(ng/mL) 
CV 
(%) 
Recovery 
(%) 
 
MAb DTPH 4.1 
 
1000 
 
1190 
 
18 
 
119 
 
1210 
 
14 
 
121 
 
 2000 1681 10 84 1876 3 94 
 
 5000 3922 14 78 4987 8 100 
RAb DTPH H-4.1 
 
1000 
 
1091 
 
7 
 
109 
 
1316 
 
10 
 
132 
  
2000 
 
2116 
 
5 
 
106 
 
2326 
 
7 
 
116 
 
 
 
5000 
 
4401 
 
13 
 
88 
 
5323 
 
19 
 
107 
 
RAb-pIII DTPH H-4.1 
 
1000 
 
1172 
 
1 
 
117 
 
1449 
 
15 
 
145 
 
 
 
2000 
 
2151 
 
12 
 
108 
 
2647 
 
8 
 
132 
 
 
 
5000 
 
4757 
 
7 
 
95 
 
6390 
 
6 
 
128 
 
RAb DTPH L-1.2 
 
1000 
 
875 
 
3 
 
88 
 
1178 
 
7 
 
118 
 
 
 
2000 
 
1823 
 
8 
 
91 
 
2519 
 
12 
 
126 
 
 
 
5000 
 
4051 
 
21 
 
81 
 
5190 
 
10 
 
104 
 
RAb-pIII DTPH L-1.2 
 
1000 
 
1006 
 
24 
 
101 
 
1300 
 
12 
 
130 
 
 
 
2000 
 
2036 
 
7 
 
102 
 
2724 
 
8 
 
136 
  
5000 
 
3969 
 
13 
 
79 
 
5274 
 
3 
 
106 
a
 Data are the average of four independent determinations. 
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Figure 1. Structure of tetraconazole and of the immunizing hapten DTPH.  
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Figure 2. ELISA standard curves for tetraconazole using MAb DTPH 4.1 (■), RAb 
DTPH H-4.1 (●) and RAb DTPH L-1.2 (▲). Each point represents the mean value of 
four replicates ± standard deviation. 
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